Company
Headquarters: San Francisco, CA, United States
Employees: 1,700
CEO: Mr. Quentin S. Blackford
$5.65 Billion
USD as of Jan. 1, 2026
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $201.46 B |
| EssilorLuxottica SA | $144.43 B |
| Becton, Dickinson and Company | $55.63 B |
| HOYA Corp | $50.63 B |
| Alcon Inc. | $39.46 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
| Last Financial Reports Date | Sept. 30, 2025 |
| Revenue TTM | $702.6 M |
| EBITDA | $-41,065,000 |
| Gross Profit TTM | $494.3 M |
| Profit Margin | -7.32% |
| Operating Margin | -2.08% |
| Quarterly Revenue Growth | 30.70% |
iRhythm Technologies, Inc. has the following listings and related stock indices.
Stock: NASDAQ: IRTC
Stock: FSX: I25